FDA Clearance Tracker · P210032-S007
GORE TAG Thoracic Branch Endoprosthesis (TBE Device)
Last checked: Nov 20, 2026Latest source record: May 2, 2023 (this decision)Source: openFDAMethods & limitations
Decided
May 2, 2023
Approved
Time to decision
84 days
Received Feb 7, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P210032-S007
- Device name
- GORE TAG Thoracic Branch Endoprosthesis (TBE Device)
- Applicant
- W. L. Gore & Associates, Inc.
- Applicant location
- Flagstaff, AZ
- Received
- Feb 7, 2023
- Decided
- May 2, 2023
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P210032
Device type
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval for an expansion of the indications for use and modifications to the Instructions for Use of the Gore TAG Thoracic Branch Endoprosthesis (TBE Device).
Source documents
Other decisions for W. L. Gore & Associates, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- GORE® VIABAHN® VBX Balloon Expandable EndoprosthesisPMA supplement
P160021-S051 · Decided Oct 8, 2026 · 244 days after receipt · Panel Track
Device type: Iliac covered stent, arterial (PRL) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.